| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.43B | +3.6% | +12.6% |
| R&D Expense | $666.0M | +0.9% | +2.9% |
| SG&A Expense | $234.0M | +8.3% | +18.2% |
| Operating Income | $259.0M | +4.4% | +57.0% |
| Interest Expense | $29.0M | +0.0% | +0.0% |
| Pre-tax Income | $338.0M | +11.2% | +48.9% |
| Income Tax | $86.0M | +13.2% | +152.9% |
| Net Income | $252.0M | +10.5% | +30.6% |
| EPS (Basic) | $0.95 | +10.5% | +30.1% |
| EPS (Diluted) | $0.94 | +11.9% | +30.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.61B | +106.4% | +99.0% |
| Short-term Investments | $4.23B | -38.8% | -27.6% |
| Accounts Receivable | $1.75B | +8.8% | +24.6% |
| Current Assets | $9.18B | -11.8% | +1.1% |
| Total Assets | $17.75B | -1.2% | +8.1% |
| Current Liabilities | $5.02B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.66B | — | +309.1% |
| Capital Expenditures | $102.0M | — | +117.0% |
| Investing Cash Flow | $1.18B | — | +361.6% |
| Financing Cash Flow | -$1.77B | — | -529.4% |
| Free Cash Flow | $1.56B | — | +334.3% |
| +13.5% |
| Long-term Debt | $2.99B | +0.0% | +0.1% |
| Total Liabilities | $8.87B | +0.9% | +13.7% |
| Stockholders' Equity | $8.88B | -3.2% | +3.0% |